Large-scale testing (Phase 3)Study completedNCT03877926What this trial is testingVELOCITY: An Anthrax Vaccine Clinical StudyWho this might be right forAnthrax Emergent BioSolutions 3,862
Testing effectiveness (Phase 2)Study completedNCT00170456What this trial is testingPhase II Study of Range and Schedule of rPA DosesWho this might be right forPrevention of Bacillus Anthracis (Anthrax) Infection PharmAthene UK Limited 415
Post-approval studies (Phase 4)Study completedNCT01641991What this trial is testingAssessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA ScheduleWho this might be right forBacillus Anthracis (Anthrax) National Institute of Allergy and Infectious Diseases (NIAID) 328
Not applicableNot Yet RecruitingNCT07268612What this trial is testingEvaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.Who this might be right forAnthrax Emergent BioSolutions 250